This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/7140565.stm
The article has changed 3 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
Approval for once-a-day HIV pill | Approval for once-a-day HIV pill |
(about 1 hour later) | |
The first HIV medication which involves taking just one pill a day has been approved by the European authorities. | |
The go-ahead for Atripla represents what some experts say is a revolution in treatment for the virus that causes Aids, although it is not a cure. | |
People using the earliest HIV drugs in 1996 had to take up to 30 pills on an empty stomach at different times. | |
The decision means Atripla can be used in the UK but local health bodies must decide whether the NHS will provide it. | |
This is a big advance for patients - it almost normalises HIV Dr Simon PortsmouthHIV consultant | This is a big advance for patients - it almost normalises HIV Dr Simon PortsmouthHIV consultant |
Taking Atripla does not reduce the risk of transmitting the virus. | Taking Atripla does not reduce the risk of transmitting the virus. |
The drugs regime has already reduced to just several pills a day for people newly diagnosed with HIV. | The drugs regime has already reduced to just several pills a day for people newly diagnosed with HIV. |
Rival companies | Rival companies |
But it is highly symbolic that managing the condition will, for some patients, now become almost as simple as taking a daily statin tablet. | But it is highly symbolic that managing the condition will, for some patients, now become almost as simple as taking a daily statin tablet. |
Atripla combines three existing drugs. It has come into existence as a result of collaboration between three rival drug companies - Gilead Sciences, Bristol-Myers Squibb and Merck. | Atripla combines three existing drugs. It has come into existence as a result of collaboration between three rival drug companies - Gilead Sciences, Bristol-Myers Squibb and Merck. |
The single pill was licensed in the US in July last year - and is now given to half of all patients who are newly diagnosed there. | The single pill was licensed in the US in July last year - and is now given to half of all patients who are newly diagnosed there. |
Approval by the European Commission means Atripla will soon be available to people with HIV in Germany, Austria and the UK. | Approval by the European Commission means Atripla will soon be available to people with HIV in Germany, Austria and the UK. |
In the UK, it will be available through the NHS, but this will be at the discretion of primary care trusts (PCTs)and GPs. | |
Dr Simon Portsmouth, a leading HIV consultant, said: "This is a big advance for patients. It almost normalises HIV. | Dr Simon Portsmouth, a leading HIV consultant, said: "This is a big advance for patients. It almost normalises HIV. |
"They can just take this pill before they go to bed at night, and it doesn't take over their whole life." | "They can just take this pill before they go to bed at night, and it doesn't take over their whole life." |
Dr Portsmouth, based at St Mary's Hospital in west London, added: "Because we've been using the components of Atripla for some time, we know what side effects to expect. | Dr Portsmouth, based at St Mary's Hospital in west London, added: "Because we've been using the components of Atripla for some time, we know what side effects to expect. |
"Probably more than half of patients initially will get some dizziness, or abnormal dreams, or sleep disturbance. But generally this medicine is pretty well-tolerated. | "Probably more than half of patients initially will get some dizziness, or abnormal dreams, or sleep disturbance. But generally this medicine is pretty well-tolerated. |
"And we'll spend lots of time with each person, explaining the drug and why they need to take it carefully all the time." | "And we'll spend lots of time with each person, explaining the drug and why they need to take it carefully all the time." |
Not straightforward | Not straightforward |
Gilead senior vice-president Paul Carter said: "There has been a huge amount of manufacturing work to bring this drug to the market. | Gilead senior vice-president Paul Carter said: "There has been a huge amount of manufacturing work to bring this drug to the market. |
"Trying to get three drugs into one pill isn't a straightforward procedure. | "Trying to get three drugs into one pill isn't a straightforward procedure. |
"But nevertheless we anticipate that across Europe, Atripla will be available at a price which is in parity with the sum of its component parts." | "But nevertheless we anticipate that across Europe, Atripla will be available at a price which is in parity with the sum of its component parts." |
Merck, meanwhile, is taking a lead in trying to make the pill available to people with HIV in Africa, at a lower price. | Merck, meanwhile, is taking a lead in trying to make the pill available to people with HIV in Africa, at a lower price. |
Mr Carter pointed out that drug development in this field is a never-ending task. | Mr Carter pointed out that drug development in this field is a never-ending task. |
"We see plenty of room for better treatments in the years ahead," he said. | "We see plenty of room for better treatments in the years ahead," he said. |
"It's a key issue that HIV builds up resistance, and therefore the industry needs a continual pipeline of new drugs." | "It's a key issue that HIV builds up resistance, and therefore the industry needs a continual pipeline of new drugs." |